Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-06 | 2019-03-09 | 77971 |
APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-03-06 | 2019-09-09 | 77974 |
IBUPROFEN | 200MG | TABLET | Resolved | 2019-03-13 | 2019-08-28 | 78461 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-13 | 2019-07-12 | 78484 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2019-03-13 | 2019-08-31 | 78497 |
APO-GABAPENTIN | 600MG | TABLET | Resolved | 2019-03-13 | 2019-07-04 | 78505 |
APO-IMATINIB | 400MG | TABLET | Resolved | 2019-03-13 | 2019-03-29 | 78512 |
APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-03 | 78526 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2019-03-13 | 2019-05-06 | 78529 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-13 | 78536 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-13 | 78541 |
APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2019-03-13 | 2019-04-05 | 78555 |
TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-03-13 | 2019-05-21 | 78558 |
APO-ALPRAZ | 0.25MG | TABLET | Resolved | 2019-03-20 | 2019-09-16 | 79036 |
APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-20 | 2020-04-04 | 79039 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2019-03-20 | 2020-04-01 | 79042 |
APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2019-03-20 | 2019-04-26 | 79045 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-03-20 | 2019-07-06 | 79048 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2019-03-20 | 2019-04-26 | 79051 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-27 | 2019-03-29 | 79574 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-DIPYRIDAMOLE | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
APO-DIPYRIDAMOLE | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |